About Index Trending news
Lists
Pricing
Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development. .

Elsewhere

Contributors to this profile

Alexa global traffic share

07 Feb 2017

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo
+1
05 Jan 2017
£23,000,000
Venture capital (Series B)

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
15 Jun 2016

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire
+1
07 Jan 2016
$60,000,000
Venture capital (Series B)

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire
+2
11 Mar 2014
$27,000,000
Venture capital (Series B)

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v
+1
25 Jul 2012
04 Feb 2011
11 May 2010
$20,000,000
Venture capital (Series A)
12 Mar 2010